NCT07124832

Brief Summary

The goal of this clinical trial is to evaluate the feasibility of using Socratic questioning as an alternative method for weight loss in adult patients with obesity (aged 18 to 65) in a primary care setting. The main question it aims to answer is:

  • Is Socratic questioning an effective alternative approach for promoting weight loss in patients with obesity? Researchers will compare participants receiving Socratic questioning during follow-up visits with those receiving regular care to see if the intervention leads to greater weight loss. Participants will:
  • Complete a baseline questionnaire including 9 demographic questions and the 14-item Hospital Anxiety and Depression Scale (approx. 5 minutes).
  • Attend five in-person follow-up visits with their family physician over a 3-month period (every 15 or 30 days), where they will receive brief counseling (10-15 minutes per visit) and have their weight, height, and waist circumference measured.
  • Complete a 17-question final questionnaire at the end of 3 months (approx. 10-15 minutes).
  • Be referred to mental health services if necessary, based on initial screening results.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 6, 2025

Completed
8 days until next milestone

Study Start

First participant enrolled

August 14, 2025

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 15, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

August 29, 2025

Status Verified

August 1, 2025

Enrollment Period

3 months

First QC Date

August 6, 2025

Last Update Submit

August 23, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline in Body Weight at 3 Months

    Body weight will be measured in kilograms using a calibrated digital scale. The outcome is the difference in percent change in body weight from baseline to 3 months between the Socratic questioning intervention group and the regular care control group.

    Baseline and 3 months

Secondary Outcomes (4)

  • Change from Baseline in Body Mass Index (BMI) at 3 Months

    Baseline and 3 months

  • Change from Baseline in Waist Circumference at 3 Months

    Baseline and 3 months

  • Association Between Weight Loss Percentage and Previous Attempts to Lose Weight

    Baseline and 3 months

  • Correlation Between Weight Loss Percentage and Baseline Willingness

    Baseline and 3 months

Study Arms (2)

Socratic Questioning Group

ACTIVE COMPARATOR

Participants in the intervention group will be followed up by physicians using the Socratic questioning technique. Face-to-face meetings will be held on the 0th, 15th, 30th and 60th days, and each session will take approximately 10-15 minutes. Physicians will use a checklist and ICD-10 code (E66: Obesity) when recording participant notes. The group to which the participant is assigned will be indicated in the Family Medicine Information System, and this warning note will be visible to physicians at each examination. Researchers will not interfere with the content of the interview, and physicians will be given flexibility to apply the Socratic questioning technique according to the needs of the participant.

Behavioral: Socratic Questioning Method

Regular Care Group

NO INTERVENTION

Participants in the control group will be followed up with the routine obesity approach used by physicians in their daily practice. Physicians will maintain the standard of care they normally give to patients with obesity. This approach may include nutritional advice, physical activity recommendations, and general lifestyle change advice, but Socratic questioning techniques will not be used.

Interventions

Socratic questioning is a method in which behaviour is examined through questions such as "what, where, which, who, when, how, and why". It consists of four stages: defining the problem, evaluating and identifying alternatives, redefining, and discussing feasible outcomes. Through this process, individuals develop their critical thinking skills and make self-evaluations.

Socratic Questioning Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18 and 65 years
  • Body Mass Index (BMI) ≥ 30 kg/m²
  • Willingness to participate in the study

You may not qualify if:

  • Pregnancy or breastfeeding
  • Presence of active psychosis or manic episode
  • Intellectual disability
  • Severe depression or personality disorder
  • Auto- or hetero-aggressive behavior
  • Reported use of psychoactive substances
  • Suicidal ideation
  • Participation in another weight loss program within the last 6 months
  • Use of medications that cause long-term weight gain or loss
  • Detection of psychopathology based on the Hospital Anxiety and Depression Scale (HADS)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Manisa Celal Bayar University Mustafa Yardimci Education Family Health Center

Manisa, 45140, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Raquel Gómez Bravo

    Centre Hospitalier Neuro-Psychiatrique, Luxembourg

    STUDY DIRECTOR
  • Vinicius Anjos de Almeida

    University of Sao Paulo

    STUDY DIRECTOR
  • Sandra León Herrera

    University of Zaragoza, Spain

    STUDY DIRECTOR
  • Sıdıka E. Yokuş

    Manisa Celal Bayar University

    PRINCIPAL INVESTIGATOR
  • Hüseyin Elbi

    Manisa Celal Bayar University

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Participants will be assigned to intervention and control groups at a 1:1 ratio using the block randomization method (block size 6) with a computer-aided program.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

August 6, 2025

First Posted

August 15, 2025

Study Start

August 14, 2025

Primary Completion

November 1, 2025

Study Completion

November 1, 2025

Last Updated

August 29, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

No data sharing plan was made due to the statement 'Your personal information will not be shared with any other person or organisation' in the ethics committee application file.

Locations